Randomised trial assessing the feasibility of recruitment & safety of transdermal GTN vs sham applied between 3-5 hours of stroke to inform a definitive trial.
Day 3: 🌈Dr Chaamanti Menon who gave a wonderful presentation in "Sex Matters in ICH. Sex Disparity Analysis from TICH-2 Data" at Women's Health in Stroke 👏 #uksf24#UKSF24
[1/2] Thurs 5th :
Please join us where Dr Menon will be presenting “Sex Matters in Intracerebral Haemorrhage”, 9.00am, room 3.
Prof. Wardlaw & Kasia Adamczuk will be presenting LACI-3, 10.30am, room 12.
#uksf24#UKSF24
Really thankful for the turnout to see Dr Krishnan, Prof Sprigg & Prof Bath present @MACE_ICH_Trial@tich3trial & #FASTEST. Thank you to those who attended to see Dr Woodhouse present @ENOS2Trial Some more updates to follow for tomorrow! #uksf24#UKSF24
Please join us today at 10.40-11.25am at room 12 where Dr Krishnan @MACE_ICH_Trial , Prof Sprigg @tich3trial & Prof Bath #FASTEST will be presenting. Big thank you to those who attended Dr Woodhouse's @ENOS2Trial presentation earlier this morning 👏 #UKSF24#uksf24
Desmopressin as a potential treatment for stroke due to intracerebral haemorrhage in people taking antiplatelet drugs.
Find out the DASH trial results here: https://t.co/Fn2Y66fYC7 This includes the publication, results video, infographic & lay summary.
Thanks to all involved!
Another huge thank you this month to all of the teams working on our multi-centre stroke trials! Below are May's top recruiters from the UK. #STUNottingham
We hope to see you at ESOC 2023 in Munich next week. Please come and visit us at our stand and investigator meeting. Details below ⬇️⬇️⬇️#STUNottingham
Another huge thank you this month to all of the teams working on our multi-centre stroke trials! Below are April's top recruiters from the UK. #STUNottingham